Global Convalescent Plasma Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 90

Published Date: 20 Oct 2021

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Convalescent Plasma Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Convalescent Plasma Therapy size is estimated to be USD  million in 2026 from USD  million in 2020, with a change  % between 2020 and 2021. The global Convalescent Plasma Therapy market size is expected to grow at a CAGR of  % for the next five years.

Market segmentation
Convalescent Plasma Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    IgM
    IgG
    IgA

Market segment by Application, can be divided into
    Prophylaxis
    Treatment

Market segment by players, this report covers
    Bio Farma
    Grifols
    Hilton Pharma
    Biotest
    BPL
    LFB
    Octapharma
    CSL Behring
    Takeda Pharmaceutical Company Limited
    Orthosera Kft

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Convalescent Plasma Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Convalescent Plasma Therapy, with revenue, gross margin and global market share of Convalescent Plasma Therapy from 2019 to 2021.
Chapter 3, the Convalescent Plasma Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Convalescent Plasma Therapy market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Convalescent Plasma Therapy research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Convalescent Plasma Therapy
    1.2 Classification of Convalescent Plasma Therapy by Type
        1.2.1 Overview: Global Convalescent Plasma Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Convalescent Plasma Therapy Revenue Market Share by Type in 2020
        1.2.3 IgM
        1.2.4 IgG
        1.2.5 IgA
    1.3 Global Convalescent Plasma Therapy Market by Application
        1.3.1 Overview: Global Convalescent Plasma Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Prophylaxis
        1.3.3 Treatment
    1.4 Global Convalescent Plasma Therapy Market Size & Forecast
    1.5 Global Convalescent Plasma Therapy Market Size and Forecast by Region
        1.5.1 Global Convalescent Plasma Therapy Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Convalescent Plasma Therapy Market Size by Region, (2016-2021)
        1.5.3 North America Convalescent Plasma Therapy Market Size and Prospect (2016-2026)
        1.5.4 Europe Convalescent Plasma Therapy Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Convalescent Plasma Therapy Market Size and Prospect (2016-2026)
        1.5.6 South America Convalescent Plasma Therapy Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Convalescent Plasma Therapy Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Convalescent Plasma Therapy Market Drivers
        1.6.2 Convalescent Plasma Therapy Market Restraints
        1.6.3 Convalescent Plasma Therapy Trends Analysis

2 Company Profiles
    2.1 Bio Farma
        2.1.1 Bio Farma Details
        2.1.2 Bio Farma Major Business
        2.1.3 Bio Farma Convalescent Plasma Therapy Product and Solutions
        2.1.4 Bio Farma Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Bio Farma Recent Developments and Future Plans
    2.2 Grifols
        2.2.1 Grifols Details
        2.2.2 Grifols Major Business
        2.2.3 Grifols Convalescent Plasma Therapy Product and Solutions
        2.2.4 Grifols Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Grifols Recent Developments and Future Plans
    2.3 Hilton Pharma
        2.3.1 Hilton Pharma Details
        2.3.2 Hilton Pharma Major Business
        2.3.3 Hilton Pharma Convalescent Plasma Therapy Product and Solutions
        2.3.4 Hilton Pharma Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Hilton Pharma Recent Developments and Future Plans
    2.4 Biotest
        2.4.1 Biotest Details
        2.4.2 Biotest Major Business
        2.4.3 Biotest Convalescent Plasma Therapy Product and Solutions
        2.4.4 Biotest Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Biotest Recent Developments and Future Plans
    2.5 BPL
        2.5.1 BPL Details
        2.5.2 BPL Major Business
        2.5.3 BPL Convalescent Plasma Therapy Product and Solutions
        2.5.4 BPL Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 BPL Recent Developments and Future Plans
    2.6 LFB
        2.6.1 LFB Details
        2.6.2 LFB Major Business
        2.6.3 LFB Convalescent Plasma Therapy Product and Solutions
        2.6.4 LFB Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 LFB Recent Developments and Future Plans
    2.7 Octapharma
        2.7.1 Octapharma Details
        2.7.2 Octapharma Major Business
        2.7.3 Octapharma Convalescent Plasma Therapy Product and Solutions
        2.7.4 Octapharma Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Octapharma Recent Developments and Future Plans
    2.8 CSL Behring
        2.8.1 CSL Behring Details
        2.8.2 CSL Behring Major Business
        2.8.3 CSL Behring Convalescent Plasma Therapy Product and Solutions
        2.8.4 CSL Behring Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 CSL Behring Recent Developments and Future Plans
    2.9 Takeda Pharmaceutical Company Limited
        2.9.1 Takeda Pharmaceutical Company Limited Details
        2.9.2 Takeda Pharmaceutical Company Limited Major Business
        2.9.3 Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Product and Solutions
        2.9.4 Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Takeda Pharmaceutical Company Limited Recent Developments and Future Plans
    2.10 Orthosera Kft
        2.10.1 Orthosera Kft Details
        2.10.2 Orthosera Kft Major Business
        2.10.3 Orthosera Kft Convalescent Plasma Therapy Product and Solutions
        2.10.4 Orthosera Kft Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Orthosera Kft Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Convalescent Plasma Therapy Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Convalescent Plasma Therapy Players Market Share
        3.2.2 Top 10 Convalescent Plasma Therapy Players Market Share
        3.2.3 Market Competition Trend
    3.3 Convalescent Plasma Therapy Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Convalescent Plasma Therapy Revenue and Market Share by Type (2016-2021)
    4.2 Global Convalescent Plasma Therapy Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global Convalescent Plasma Therapy Revenue Market Share by Application (2016-2021)
    5.2 Convalescent Plasma Therapy Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America Convalescent Plasma Therapy Revenue by Type (2016-2026)
    6.2 North America Convalescent Plasma Therapy Revenue by Application (2016-2026)
    6.3 North America Convalescent Plasma Therapy Market Size by Country
        6.3.1 North America Convalescent Plasma Therapy Revenue by Country (2016-2026)
        6.3.2 United States Convalescent Plasma Therapy Market Size and Forecast (2016-2026)
        6.3.3 Canada Convalescent Plasma Therapy Market Size and Forecast (2016-2026)
        6.3.4 Mexico Convalescent Plasma Therapy Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe Convalescent Plasma Therapy Revenue by Type (2016-2026)
    7.2 Europe Convalescent Plasma Therapy Revenue by Application (2016-2026)
    7.3 Europe Convalescent Plasma Therapy Market Size by Country
        7.3.1 Europe Convalescent Plasma Therapy Revenue by Country (2016-2026)
        7.3.2 Germany Convalescent Plasma Therapy Market Size and Forecast (2016-2026)
        7.3.3 France Convalescent Plasma Therapy Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Convalescent Plasma Therapy Market Size and Forecast (2016-2026)
        7.3.5 Russia Convalescent Plasma Therapy Market Size and Forecast (2016-2026)
        7.3.6 Italy Convalescent Plasma Therapy Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Convalescent Plasma Therapy Revenue by Type (2016-2026)
    8.2 Asia-Pacific Convalescent Plasma Therapy Revenue by Application (2016-2026)
    8.3 Asia-Pacific Convalescent Plasma Therapy Market Size by Region
        8.3.1 Asia-Pacific Convalescent Plasma Therapy Revenue by Region (2016-2026)
        8.3.2 China Convalescent Plasma Therapy Market Size and Forecast (2016-2026)
        8.3.3 Japan Convalescent Plasma Therapy Market Size and Forecast (2016-2026)
        8.3.4 South Korea Convalescent Plasma Therapy Market Size and Forecast (2016-2026)
        8.3.5 India Convalescent Plasma Therapy Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Convalescent Plasma Therapy Market Size and Forecast (2016-2026)
        8.3.7 Australia Convalescent Plasma Therapy Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America Convalescent Plasma Therapy Revenue by Type (2016-2026)
    9.2 South America Convalescent Plasma Therapy Revenue by Application (2016-2026)
    9.3 South America Convalescent Plasma Therapy Market Size by Country
        9.3.1 South America Convalescent Plasma Therapy Revenue by Country (2016-2026)
        9.3.2 Brazil Convalescent Plasma Therapy Market Size and Forecast (2016-2026)
        9.3.3 Argentina Convalescent Plasma Therapy Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Convalescent Plasma Therapy Revenue by Type (2016-2026)
    10.2 Middle East & Africa Convalescent Plasma Therapy Revenue by Application (2016-2026)
    10.3 Middle East & Africa Convalescent Plasma Therapy Market Size by Country
        10.3.1 Middle East & Africa Convalescent Plasma Therapy Revenue by Country (2016-2026)
        10.3.2 Turkey Convalescent Plasma Therapy Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Convalescent Plasma Therapy Market Size and Forecast (2016-2026)
        10.3.4 UAE Convalescent Plasma Therapy Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Convalescent Plasma Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Convalescent Plasma Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Convalescent Plasma Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Convalescent Plasma Therapy Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Convalescent Plasma Therapy Revenue Market Share by Region (2021-2026)
    Table 6. Bio Farma Corporate Information, Head Office, and Major Competitors
    Table 7. Bio Farma Major Business
    Table 8. Bio Farma Convalescent Plasma Therapy Product and Solutions
    Table 9. Bio Farma Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. Grifols Corporate Information, Head Office, and Major Competitors
    Table 11. Grifols Major Business
    Table 12. Grifols Convalescent Plasma Therapy Product and Solutions
    Table 13. Grifols Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Hilton Pharma Corporate Information, Head Office, and Major Competitors
    Table 15. Hilton Pharma Major Business
    Table 16. Hilton Pharma Convalescent Plasma Therapy Product and Solutions
    Table 17. Hilton Pharma Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. Biotest Corporate Information, Head Office, and Major Competitors
    Table 19. Biotest Major Business
    Table 20. Biotest Convalescent Plasma Therapy Product and Solutions
    Table 21. Biotest Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. BPL Corporate Information, Head Office, and Major Competitors
    Table 23. BPL Major Business
    Table 24. BPL Convalescent Plasma Therapy Product and Solutions
    Table 25. BPL Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. LFB Corporate Information, Head Office, and Major Competitors
    Table 27. LFB Major Business
    Table 28. LFB Convalescent Plasma Therapy Product and Solutions
    Table 29. LFB Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. Octapharma Corporate Information, Head Office, and Major Competitors
    Table 31. Octapharma Major Business
    Table 32. Octapharma Convalescent Plasma Therapy Product and Solutions
    Table 33. Octapharma Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. CSL Behring Corporate Information, Head Office, and Major Competitors
    Table 35. CSL Behring Major Business
    Table 36. CSL Behring Convalescent Plasma Therapy Product and Solutions
    Table 37. CSL Behring Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. Takeda Pharmaceutical Company Limited Corporate Information, Head Office, and Major Competitors
    Table 39. Takeda Pharmaceutical Company Limited Major Business
    Table 40. Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Product and Solutions
    Table 41. Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. Orthosera Kft Corporate Information, Head Office, and Major Competitors
    Table 43. Orthosera Kft Major Business
    Table 44. Orthosera Kft Convalescent Plasma Therapy Product and Solutions
    Table 45. Orthosera Kft Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. Global Convalescent Plasma Therapy Revenue (USD Million) by Players (2019-2021)
    Table 47. Global Convalescent Plasma Therapy Revenue Share by Players (2019-2021)
    Table 48. Breakdown of Convalescent Plasma Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 49. Convalescent Plasma Therapy Players Head Office, Products and Services Provided
    Table 50. Convalescent Plasma Therapy Mergers & Acquisitions in the Past Five Years
    Table 51. Convalescent Plasma Therapy New Entrants and Expansion Plans
    Table 52. Global Convalescent Plasma Therapy Revenue (USD Million) by Type (2016-2021)
    Table 53. Global Convalescent Plasma Therapy Revenue Share by Type (2016-2021)
    Table 54. Global Convalescent Plasma Therapy Revenue Forecast by Type (2021-2026)
    Table 55. Global Convalescent Plasma Therapy Revenue by Application (2016-2021)
    Table 56. Global Convalescent Plasma Therapy Revenue Forecast by Application (2021-2026)
    Table 57. North America Convalescent Plasma Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 58. North America Convalescent Plasma Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 59. North America Convalescent Plasma Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 60. North America Convalescent Plasma Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 61. North America Convalescent Plasma Therapy Revenue by Country (2016-2021) & (USD Million)
    Table 62. North America Convalescent Plasma Therapy Revenue by Country (2021-2026) & (USD Million)
    Table 63. Europe Convalescent Plasma Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 64. Europe Convalescent Plasma Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 65. Europe Convalescent Plasma Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 66. Europe Convalescent Plasma Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 67. Europe Convalescent Plasma Therapy Revenue by Country (2016-2021) & (USD Million)
    Table 68. Europe Convalescent Plasma Therapy Revenue by Country (2021-2026) & (USD Million)
    Table 69. Asia-Pacific Convalescent Plasma Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 70. Asia-Pacific Convalescent Plasma Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 71. Asia-Pacific Convalescent Plasma Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 72. Asia-Pacific Convalescent Plasma Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 73. Asia-Pacific Convalescent Plasma Therapy Revenue by Region (2016-2021) & (USD Million)
    Table 74. Asia-Pacific Convalescent Plasma Therapy Revenue by Region (2021-2026) & (USD Million)
    Table 75. South America Convalescent Plasma Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 76. South America Convalescent Plasma Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 77. South America Convalescent Plasma Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 78. South America Convalescent Plasma Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 79. South America Convalescent Plasma Therapy Revenue by Country (2016-2021) & (USD Million)
    Table 80. South America Convalescent Plasma Therapy Revenue by Country (2021-2026) & (USD Million)
    Table 81. Middle East & Africa Convalescent Plasma Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 82. Middle East & Africa Convalescent Plasma Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 83. Middle East & Africa Convalescent Plasma Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 84. Middle East & Africa Convalescent Plasma Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 85. Middle East & Africa Convalescent Plasma Therapy Revenue by Country (2016-2021) & (USD Million)
    Table 86. Middle East & Africa Convalescent Plasma Therapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Convalescent Plasma Therapy Picture
    Figure 2. Global Convalescent Plasma Therapy Revenue Market Share by Type in 2020
    Figure 3. IgM
    Figure 4. IgG
    Figure 5. IgA
    Figure 6. Convalescent Plasma Therapy Revenue Market Share by Application in 2020
    Figure 7. Prophylaxis Picture
    Figure 8. Treatment Picture
    Figure 9. Global Convalescent Plasma Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 10. Global Convalescent Plasma Therapy Revenue and Forecast (2016-2026) & (USD Million)
    Figure 11. Global Convalescent Plasma Therapy Revenue Market Share by Region (2016-2026)
    Figure 12. Global Convalescent Plasma Therapy Revenue Market Share by Region in 2020
    Figure 13. North America Convalescent Plasma Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 14. Europe Convalescent Plasma Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 15. Asia-Pacific Convalescent Plasma Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 16. South America Convalescent Plasma Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 17. Middle East and Africa Convalescent Plasma Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. Convalescent Plasma Therapy Market Drivers
    Figure 19. Convalescent Plasma Therapy Market Restraints
    Figure 20. Convalescent Plasma Therapy Market Trends
    Figure 21. Bio Farma Recent Developments and Future Plans
    Figure 22. Grifols Recent Developments and Future Plans
    Figure 23. Hilton Pharma Recent Developments and Future Plans
    Figure 24. Biotest Recent Developments and Future Plans
    Figure 25. BPL Recent Developments and Future Plans
    Figure 26. LFB Recent Developments and Future Plans
    Figure 27. Octapharma Recent Developments and Future Plans
    Figure 28. CSL Behring Recent Developments and Future Plans
    Figure 29. Takeda Pharmaceutical Company Limited Recent Developments and Future Plans
    Figure 30. Orthosera Kft Recent Developments and Future Plans
    Figure 31. Global Convalescent Plasma Therapy Revenue Share by Players in 2020
    Figure 32. Convalescent Plasma Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 33. Global Top 3 Players Convalescent Plasma Therapy Revenue Market Share in 2020
    Figure 34. Global Top 10 Players Convalescent Plasma Therapy Revenue Market Share in 2020
    Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 36. Global Convalescent Plasma Therapy Revenue Share by Type in 2020
    Figure 37. Global Convalescent Plasma Therapy Market Share Forecast by Type (2021-2026)
    Figure 38. Global Convalescent Plasma Therapy Revenue Share by Application in 2020
    Figure 39. Global Convalescent Plasma Therapy Market Share Forecast by Application (2021-2026)
    Figure 40. North America Convalescent Plasma Therapy Sales Market Share by Type (2016-2026)
    Figure 41. North America Convalescent Plasma Therapy Sales Market Share by Application (2016-2026)
    Figure 42. North America Convalescent Plasma Therapy Revenue Market Share by Country (2016-2026)
    Figure 43. United States Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 44. Canada Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 45. Mexico Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 46. Europe Convalescent Plasma Therapy Sales Market Share by Type (2016-2026)
    Figure 47. Europe Convalescent Plasma Therapy Sales Market Share by Application (2016-2026)
    Figure 48. Europe Convalescent Plasma Therapy Revenue Market Share by Country (2016-2026)
    Figure 49. Germany Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. France Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. United Kingdom Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Russia Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. Italy Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 54. Asia-Pacific Convalescent Plasma Therapy Sales Market Share by Type (2016-2026)
    Figure 55. Asia-Pacific Convalescent Plasma Therapy Sales Market Share by Application (2016-2026)
    Figure 56. Asia-Pacific Convalescent Plasma Therapy Revenue Market Share by Region (2016-2026)
    Figure 57. China Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. Japan Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. South Korea Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. India Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Southeast Asia Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. Australia Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. South America Convalescent Plasma Therapy Sales Market Share by Type (2016-2026)
    Figure 64. South America Convalescent Plasma Therapy Sales Market Share by Application (2016-2026)
    Figure 65. South America Convalescent Plasma Therapy Revenue Market Share by Country (2016-2026)
    Figure 66. Brazil Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. Argentina Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. Middle East and Africa Convalescent Plasma Therapy Sales Market Share by Type (2016-2026)
    Figure 69. Middle East and Africa Convalescent Plasma Therapy Sales Market Share by Application (2016-2026)
    Figure 70. Middle East and Africa Convalescent Plasma Therapy Revenue Market Share by Country (2016-2026)
    Figure 71. Turkey Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 72. Saudi Arabia Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. UAE Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. Methodology
    Figure 75. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Bio Farma
Grifols
Hilton Pharma
Biotest
BPL
LFB
Octapharma
CSL Behring
Takeda Pharmaceutical Company Limited
Orthosera Kft

Related Reports

Global Convalescent Plasma Therapy Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Convalescent Plasma Therapy Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 18 Jan 2022

date Medical Care

The Convalescent Plasma Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Convalescent Plasma Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Convalescent Plasma Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 13 Jan 2023

date Medical Care

Convalescent plasma is the plasma collected from the recovered or convalesced people consisting of the antibodies against the infection causing microorganism.

Global Convalescent Plasma Therapy Supply, Demand and Key Producers, 2023-2029

Global Convalescent Plasma Therapy Supply, Demand and Key Producers, 2023-2029

date 16 Feb 2023

date Medical Care

The global Convalescent Plasma Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Convalescent Plasma Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Convalescent Plasma Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 08 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Convalescent Plasma Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Convalescent Plasma Therapy Supply, Demand and Key Producers, 2024-2030

Global Convalescent Plasma Therapy Supply, Demand and Key Producers, 2024-2030

date 11 Feb 2024

date Medical Care

The global Convalescent Plasma Therapy market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

convalescent plasma therapy

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>